Gabapentin
Product Images NDC 68151-1028

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68151-1028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (68151 1028)

Label of Gabapentin 100 MG capsules displaying the manufacturer as Apotex. The label includes batch information with lot number MM9354, expiration date 10/16, and an identifier code. RX only is indicated, along with a barcode and numeric code 0000001028.*

FDA Label Image

Figure1 (Figure1)

A line graph depicting mean pain scores over 8 weeks comparing placebo and Gabapentin 3600 mg/day. The graph shows a 4-week dose titration period followed by a 4-week fixed dose period. Mean pain scores decrease over time more prominently for Gabapentin compared to placebo.*

FDA Label Image

Figure2 (Figure2)

A line graph showing mean pain score over 7 weeks for three groups: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The x-axis represents weeks including baseline, highlighting a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis depicts mean pain scores from 0 to 10. Gabapentin groups show decreasing pain scores compared to placebo.*

FDA Label Image

Figure3 (Figure3)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' compares response rates across two studies. It shows percentages for placebo (PBO) and gabapentin (GBP) at different doses (3600 mg in Study 1; 1800 mg and 2400 mg in Study 2). The chart includes significance markers with p-values less than 0.01 and 0.001 noted.*

FDA Label Image

Figure4 (Figure4)

A scatter plot graph showing differences (%) on the y-axis and daily dose (mg) on the x-axis with data points from three studies labeled a, b, and c. The plot compares differences at various doses (600, 900, 1200, 1800 mg) for studies a, b, and c, indicating variations in percentage difference relative to daily dose.*

FDA Label Image

Scale (Scale)

A formula for calculating creatinine clearance (CLCr) is shown, which includes age in years, weight in kilograms, serum creatinine in mg/dL, and a multiplication factor of 0.85 for female patients.*

FDA Label Image

Structuralformula (Structuralformula)

Chemical structure of gabapentin showing a cyclohexane ring attached to two functional groups: a CH2NH2 (amino methyl) group and a CH2CO2H (carboxymethyl) group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.